Serene Sleep develops a minimally invasive, one-time procedure to treat snoring and obstructive sleep apnea (OSA). This solution utilizes palatal implants to gently stiffen soft palate tissue, thereby maintaining open airways during sleep. The company offers an alternative to traditional treatments like CPAP masks or surgery for well-selected patients.
Funding
Funding not disclosed
Founders
Product
Problem
Snoring and mild-to-moderate sleep apnea affect millions, with current treatment options often proving unsatisfactory for patients and providers. This leads to persistent sleep disturbances and a demand for more effective therapeutic interventions.
Solution
Serene Sleep is developing a minimally invasive palatal implant system designed to address snoring and sleep apnea. This novel therapeutic approach aims to provide a more effective and patient-friendly alternative to existing treatments. The company is focused on obtaining regulatory clearance to bring this solution to market, thereby improving sleep quality for a significant patient population.
Target Audience
The primary target audience includes Ear, Nose, and Throat (ENT) specialists and sleep medicine providers who are seeking advanced treatment options for their patients.
Features
- Minimally invasive palatal implant system for the treatment of snoring and sleep apnea.
- Designed to offer an improved therapeutic outcome compared to current market offerings.
- Undergoing clinical trials and seeking 510(k) clearance for market entry.